Formulation

Transform active ingredients into stable, commercially scalable, and high-performing formulations.

From active ingredients to market-ready products

We specialise in transforming active ingredients into commercially viable and stable products through advanced formulation science. Leveraging our extensive expertise, we optimise the stability, viability, and shelf-life of both liquid and solid formulations, accelerating your product’s path from concept to market. 

CPI expert operating LABMAN equipment.

Formulation

Transform active ingredients into stable, commercially scalable, and high-performing formulations.

From active ingredients to market-ready products

We specialise in transforming active ingredients into commercially viable and stable products through advanced formulation science. Leveraging our extensive expertise, we optimise the stability, viability, and shelf-life of both liquid and solid formulations, accelerating your product’s path from concept to market. 

CPI expert operating LABMAN equipment.

Formulation

Transform active ingredients into stable, commercially scalable, and high-performing formulations.

From active ingredients to market-ready products

We specialise in transforming active ingredients into commercially viable and stable products through advanced formulation science. Leveraging our extensive expertise, we optimise the stability, viability, and shelf-life of both liquid and solid formulations, accelerating your product’s path from concept to market. 

  • Oxford Biotrans
  • Calysta
  • Azotic
  • 3D Bio-Tissues
  • Newcastle University
  • Immune Boost Clinic

What we offer

We combine deep scientific knowledge and cutting-edge formulation technologies to deliver commercially viable products. We offer a comprehensive range of techniques to develop stable, scalable formulations tailored to your unique needs.

What we offer

We combine deep scientific knowledge and cutting-edge formulation technologies to deliver commercially viable products. We offer a comprehensive range of techniques to develop stable, scalable formulations tailored to your unique needs.

What we offer

We combine deep scientific knowledge and cutting-edge formulation technologies to deliver commercially viable products. We offer a comprehensive range of techniques to develop stable, scalable formulations tailored to your unique needs.

Advanced encapsulation techniques

We apply a range of encapsulation methods to enhance product stability, shelf-life, and controlled release performance: 

  • Microfluidics-based encapsulation. 

  • Techniques supporting sensitive biological ingredients and bioactives. 

  • Controlled-release solutions. 

Advanced encapsulation techniques

We apply a range of encapsulation methods to enhance product stability, shelf-life, and controlled release performance: 

  • Microfluidics-based encapsulation. 

  • Techniques supporting sensitive biological ingredients and bioactives. 

  • Controlled-release solutions. 

Stability and shelf-life optimisation

We focus on optimising the stability and viability of both liquid and dry formulations to extend shelf life and maintain product integrity using a range of techniques: 

  • Spray drying, freeze drying, fluidised bed drying, vacuum drying. 

  • Extrusion and milling techniques for optimal particle size and form. 

  • Formulation processes minimising dust formation and enhancing product handling. 

Stability and shelf-life optimisation

We focus on optimising the stability and viability of both liquid and dry formulations to extend shelf life and maintain product integrity using a range of techniques: 

  • Spray drying, freeze drying, fluidised bed drying, vacuum drying. 

  • Extrusion and milling techniques for optimal particle size and form. 

  • Formulation processes minimising dust formation and enhancing product handling. 

High-throughput screening and optimisation

Our automated formulation screening and AI-driven Design of Experiments (DOE) methodologies significantly accelerate product development: 

  • Rapid identification of optimal formulation parameters. 

  • Reduction of development time and cost. 

  • Enhanced formulation robustness and scalability. 

High-throughput screening and optimisation

Our automated formulation screening and AI-driven Design of Experiments (DOE) methodologies significantly accelerate product development: 

  • Rapid identification of optimal formulation parameters. 

  • Reduction of development time and cost. 

  • Enhanced formulation robustness and scalability. 

Analytical formulation characterisation

We employ extensive analytical capabilities to ensure precise formulation structure, texture, and bioavailability: 

  • Characterisation of particle size, microstructure, and surface properties. 

  • Determination of encapsulation efficiency, cargo viability, and stability. 

  • Evaluation of loading and release kinetics to optimise performance.  

Analytical formulation characterisation

We employ extensive analytical capabilities to ensure precise formulation structure, texture, and bioavailability: 

  • Characterisation of particle size, microstructure, and surface properties. 

  • Determination of encapsulation efficiency, cargo viability, and stability. 

  • Evaluation of loading and release kinetics to optimise performance.  

How we support you

At CPI, we offer access to industry-relevant formulation and scale-up infrastructure, alongside industry-experienced scientists and technologists, ensuring a smooth transition from early-stage research to commercial-scale manufacturing.

How we support you

At CPI, we offer access to industry-relevant formulation and scale-up infrastructure, alongside industry-experienced scientists and technologists, ensuring a smooth transition from early-stage research to commercial-scale manufacturing.

How we support you

At CPI, we offer access to industry-relevant formulation and scale-up infrastructure, alongside industry-experienced scientists and technologists, ensuring a smooth transition from early-stage research to commercial-scale manufacturing.

Optimise and de-risk your formulations 

We help you navigate the complexities of formulation development, improving stability, shelf-life, and scalability. Our expertise spans from proof-of-concept through to industrial production, ensuring that your formulation is robust and commercially viable. 

Optimise and de-risk your formulations 

We help you navigate the complexities of formulation development, improving stability, shelf-life, and scalability. Our expertise spans from proof-of-concept through to industrial production, ensuring that your formulation is robust and commercially viable. 

Scale with confidence 

Scaling formulations from lab to full-scale production can be challenging. We provide access to advanced pilot and demonstration-scale formulation facilities, enabling you to validate and refine your processes. Our techno-economic analyses and formulation validation studies help de-risk your scale-up, ensuring a successful transition to commercial production. 

Scale with confidence 

Scaling formulations from lab to full-scale production can be challenging. We provide access to advanced pilot and demonstration-scale formulation facilities, enabling you to validate and refine your processes. Our techno-economic analyses and formulation validation studies help de-risk your scale-up, ensuring a successful transition to commercial production. 

Intellectual property development and protection 

We help you develop and secure your own IP by providing an established environment for innovation. Our expert formulation teams work closely with you to develop proprietary formulations, methods, and processes, maintaining your competitive edge. 

Intellectual property development and protection 

We help you develop and secure your own IP by providing an established environment for innovation. Our expert formulation teams work closely with you to develop proprietary formulations, methods, and processes, maintaining your competitive edge. 

Navigate regulatory and commercial hurdles 

We employ extensive analytical capabilities to ensure precise formulation structure, texture, and bioavailability: 

  • Characterisation of particle size, microstructure, and surface properties. 

  • Determination of encapsulation efficiency, cargo viability, and stability. 

  • Evaluation of loading and release kinetics to optimise performance.  

Navigate regulatory and commercial hurdles 

We employ extensive analytical capabilities to ensure precise formulation structure, texture, and bioavailability: 

  • Characterisation of particle size, microstructure, and surface properties. 

  • Determination of encapsulation efficiency, cargo viability, and stability. 

  • Evaluation of loading and release kinetics to optimise performance.  

Facilitate investment and accelerate innovation 

Securing investment is essential for scaling new formulations. We support you in obtaining public and private funding through grant applications and strategic partnerships. By collaborating with industry, academia, and government, we offer access to critical funding opportunities, expertise, and market insights, accelerating your formulation development journey. 

Facilitate investment and accelerate innovation 

Securing investment is essential for scaling new formulations. We support you in obtaining public and private funding through grant applications and strategic partnerships. By collaborating with industry, academia, and government, we offer access to critical funding opportunities, expertise, and market insights, accelerating your formulation development journey. 

  • CPI scientist operating an automated powder filling line, handling white tubs on the conveyor.
    Gloved scientist using a pipette to fill blue microplates at a laboratory bench.
  • Automated sampler probe dipping into a sample tube in a rack, with a CPI scientist watching behind.
    Close-up of blue-capped Fisherbrand 500 ml glass reagent bottles on a bench.
  • Gloved hand feeding tubing into a beaker of bright pink liquid at a laboratory bench.
  • CPI scientist working at a HEL parallel automated reactor system behind a glass door.
    CPI scientist drawing a process diagram on a glass screen in a laboratory.
  • Gloved hands holding a petri dish with a bacterial streak culture while using an inoculation tool.
    CPI scientist using an Olympus microscope with the magnified sample shown on a monitor.
  • Gloved hand holding a petri dish with orange bacterial colonies streaked across the agar.
  • CPI scientist operating an automated powder filling line, handling white tubs on the conveyor.
    Gloved scientist using a pipette to fill blue microplates at a laboratory bench.
  • Automated sampler probe dipping into a sample tube in a rack, with a CPI scientist watching behind.
    Close-up of blue-capped Fisherbrand 500 ml glass reagent bottles on a bench.
  • Gloved hand feeding tubing into a beaker of bright pink liquid at a laboratory bench.
  • CPI scientist working at a HEL parallel automated reactor system behind a glass door.
    CPI scientist drawing a process diagram on a glass screen in a laboratory.
  • Gloved hands holding a petri dish with a bacterial streak culture while using an inoculation tool.
    CPI scientist using an Olympus microscope with the magnified sample shown on a monitor.
  • Gloved hand holding a petri dish with orange bacterial colonies streaked across the agar.
  • CPI scientist operating an automated powder filling line, handling white tubs on the conveyor.
    Gloved scientist using a pipette to fill blue microplates at a laboratory bench.
  • Automated sampler probe dipping into a sample tube in a rack, with a CPI scientist watching behind.
    Close-up of blue-capped Fisherbrand 500 ml glass reagent bottles on a bench.
  • Gloved hand feeding tubing into a beaker of bright pink liquid at a laboratory bench.
  • CPI scientist working at a HEL parallel automated reactor system behind a glass door.
    CPI scientist drawing a process diagram on a glass screen in a laboratory.
  • Gloved hands holding a petri dish with a bacterial streak culture while using an inoculation tool.
    CPI scientist using an Olympus microscope with the magnified sample shown on a monitor.
  • Gloved hand holding a petri dish with orange bacterial colonies streaked across the agar.
£
0
1
2
3
bn

private investment unlocked

0
1
,
0
1
2
3
4
5
6
7
8
0
0
+

R&D projects delivered

0
1
2
0
+

years of experience

0
1
2
,
0
1
2
3
4
5
6
7
8
0
0
+

business collaborations

0
1
2
0
1
2
3
4
5
,
0
0
0

facilities

£
0
1
2
0
1
2
0
m

innovation assets

£
0
1
2
3
bn

private investment unlocked

0
1
,
0
1
2
3
4
5
6
7
8
0
0
+

R&D projects delivered

0
1
2
0
+

years of experience

0
1
2
,
0
1
2
3
4
5
6
7
8
0
0
+

business collaborations

0
1
2
0
1
2
3
4
5
,
0
0
0

facilities

£
0
1
2
0
1
2
0
m

innovation assets

£
0
1
2
3
bn

private investment unlocked

0
1
,
0
1
2
3
4
5
6
7
8
0
0
+

R&D projects delivered

0
1
2
0
+

years of experience

0
1
2
,
0
1
2
3
4
5
6
7
8
0
0
+

business collaborations

0
1
2
0
1
2
3
4
5
,
0
0
0

facilities

£
0
1
2
0
1
2
0
m

innovation assets

Trusted by leading organisations

Showing slide 1 of 1
Oxford Biotrans

Our project with CPI was the springboard for our technology commercialisation programme and subsequent market launch. The CPI team were knowledgeable, approachable and responsive and proved invaluable in rapidly overcoming the complex challenges that developing any new process requires.

A headshot of Jason King. .

Jason King

CEO

Touchlight Genetics

CPI has skillsets and equipment that are not readily available anywhere else. By using CPI’s skills, we have saved many months of process development.

Headshot of Dr Jill Makin, CTO

Dr Jill Makin

CTO

Calysta

We chose Teesside as a preferred location due to the commercial attractiveness, technical skills and research and development expertise in the area.

Headshot of Alan Shaw, CEO

Alan Shaw

CEO

Trusted by leading organisations

Showing slide 1 of 1
Oxford Biotrans

Our project with CPI was the springboard for our technology commercialisation programme and subsequent market launch. The CPI team were knowledgeable, approachable and responsive and proved invaluable in rapidly overcoming the complex challenges that developing any new process requires.

A headshot of Jason King. .

Jason King

CEO

Touchlight Genetics

CPI has skillsets and equipment that are not readily available anywhere else. By using CPI’s skills, we have saved many months of process development.

Headshot of Dr Jill Makin, CTO

Dr Jill Makin

CTO

Calysta

We chose Teesside as a preferred location due to the commercial attractiveness, technical skills and research and development expertise in the area.

Headshot of Alan Shaw, CEO

Alan Shaw

CEO

Trusted by leading organisations

Showing slide 1 of 1
Oxford Biotrans

Our project with CPI was the springboard for our technology commercialisation programme and subsequent market launch. The CPI team were knowledgeable, approachable and responsive and proved invaluable in rapidly overcoming the complex challenges that developing any new process requires.

A headshot of Jason King. .

Jason King

CEO

Touchlight Genetics

CPI has skillsets and equipment that are not readily available anywhere else. By using CPI’s skills, we have saved many months of process development.

Headshot of Dr Jill Makin, CTO

Dr Jill Makin

CTO

Calysta

We chose Teesside as a preferred location due to the commercial attractiveness, technical skills and research and development expertise in the area.

Headshot of Alan Shaw, CEO

Alan Shaw

CEO

Get in touch

Get in touch

Get in touch

More in Bioprocess development and scale-up